Joshua A Kazam insider trades: Allogene Therapeutics (ALLO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joshua reports to the SEC
and 6 more companies
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | ALLO | ↑ Buy | 15,000 | $12.60 | $189K | Direct | Jan 14, 2022 (2d) |
| Mar 5, 2019 | EAGL | ↑ Buy | 5,000 | $10.20 | $51K | Direct | Mar 5, 2019 (0d) |
| Mar 1, 2019 | EAGL | ↑ Buy | 5,000 | $10.13 | $51K | Direct | Mar 1, 2019 (0d) |
| Jan 21, 2015 | CAPR | ↑ Buy | 7,096 | $3.52 | $25K | Direct | Jan 22, 2015 (1d) |
| Mar 12, 2009 | NLTX | ↑ Buy | 510 | $0.75 | $383 | Direct | Mar 13, 2009 (1d) |
| Dec 16, 2008 | NLTX | ↑ Buy | 3,100 | $1.15 | $4K | Direct | Dec 16, 2008 (0d) |
| Dec 15, 2008 | NLTX | ↑ Buy | 2,500 | $1.05 | $3K | Direct | Dec 15, 2008 (0d) |
| Dec 12, 2008 | NLTX | ↑ Buy | 8,200 | $1.13 | $9K | Direct | Dec 12, 2008 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALLO insiders
Open-market trades in the last 12 months
About Joshua A Kazam's insider trades
Joshua A Kazam is a director at Allogene Therapeutics (ALLO). Since Dec 12, 2008, Joshua has reported 8 open-market purchases worth $332K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (28 filings), other transactions (19 filings), gifts (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.